Improving Research Using the Physician, Patient Experience and Tech-Enabled Solutions
In this presentation, Elligo offers an overview of steps to reopen sites, both for those working on restarting existing programs and those looking to start new ones, by utilizing patient and principal investigator feedback from existing sites, using tech-enabled solutions and developing standard operating procedures to instill new best practices post-COVID-19 lockdown. On demand presentation Register free
Register Free:
Event Overview:
The COVID-19 pandemic brought most of the world to standstill, with quarantine making it difficult for physicians and patients to start new research programs within their practice or to restart their existing studies. As more healthcare practices open to provide care for their patients, what considerations need to be made to make sure healthcare workers and patients can access their treatments in a safe environment while keeping research programs compliant without compromising study quality or data integrity?
In this presentation, Elligo offers an overview of steps to reopen sites, both for those working on restarting existing programs and those looking to start new ones, by utilizing patient and principal investigator feedback from existing sites, using tech-enabled solutions and developing standard operating procedures to instill new best practices post-COVID-19 lockdown.
Key Learning Objectives:
Operational considerations and innovations for:
- How to know when a site is ready to reopen.
- Restarting research sites and studies that were in a lockdown environment due to COVID-19 in coordination with practice partners, study sponsors and CROs.
- Instilling a “back on track” mentality and available technology solutions across operations for enrollment and visits for on-hold or delayed studies.
Speakers: Faith Holmes, M.D., Medical Director, Elligo
Jacylyn Bodmer, Chief Information & Technology Officer, Elligo
Time and Date: On demand presentation
Sponsor: Elligo
Register Free:
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Related Articles
- The Impact of ICH E6(R3) on Biospecimen Management
June 25th 2025
- The Top 5 Myths About eCOAs In 2025
March 25th 2025